Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-18

Clinical Trial Update: Improving the Efficacy of Anti-Nicotine Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 results are posted for a trial evaluating anti-nicotine immunotherapy to treat nicotine dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alexey Mukhin | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2013-12-18